Sagimet Biosciences Inc.

NasdaqGM:SGMT Stock Report

Market Cap: US$113.0m

Sagimet Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:SGMT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
19 Jul 24SellUS$43,605George KembleIndividual14,062US$3.10
19 Jul 24SellUS$33,830Elizabeth RozekIndividual10,914US$3.10
19 Jul 24SellUS$25,910Eduardo MartinsIndividual8,357US$3.10
26 Mar 24BuyUS$63,731David HappelIndividual12,100US$5.27

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of SGMT?
Owner TypeNumber of SharesOwnership Percentage
Public Companies1,654,7015.14%
Hedge Funds2,316,5727.2%
Individual Insiders3,375,46710.5%
VC/PE Firms3,899,75012.1%
General Public7,509,70023.3%
Institutions13,439,15541.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 70.35% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.2%
Point72 Asset Management, L.P.
2,316,572US$8.1m-3.23%0.02%
6.21%
New Enterprise Associates, Inc.
2,000,275US$7.0m0%0.39%
5.9%
Kleiner Perkins Caufield & Byers
1,899,475US$6.7m0%1.64%
5.14%
Jinzi Jason Wu
1,654,701US$5.8m0%no data
5.14%
Ascletis Pharma Inc.
1,654,701US$5.8m0%no data
4.11%
CHI Advisors LLC
1,323,877US$4.6m-20.9%3.18%
4.01%
Alyeska Investment Group, L.P.
1,290,512US$4.5m-6.37%0.02%
3.51%
The Vanguard Group, Inc.
1,131,127US$4.0m7.98%no data
3.45%
Baker Bros. Advisors LP
1,109,587US$3.9m-27.9%0.04%
3.3%
Rushu Luo
1,062,998US$3.7m0%no data
3.04%
BlackRock, Inc.
978,723US$3.4m2.74%no data
2.45%
Rock Springs Capital Management LP
787,808US$2.8m0%0.12%
2.31%
Citadel Advisors LLC
744,532US$2.6m-38.8%no data
2.25%
Hillhouse Investment Management, Ltd.
724,800US$2.5m0%0.03%
2.25%
Artal Group S.A.
724,771US$2.5m0%0.09%
2.15%
Millennium Management LLC
693,247US$2.4m257%no data
2.02%
PFM Health Sciences, LP
649,006US$2.3m0%0.18%
1.03%
UBS Asset Management AG
333,160US$1.2m136%no data
0.86%
Morgan Stanley, Investment Banking and Brokerage Investments
278,195US$976.5k2.49%no data
0.8%
Dennis Hom
257,569US$904.1k0%no data
0.79%
Geode Capital Management, LLC
255,236US$895.9k1.16%no data
0.7%
Bridgeway Capital Management, LLC
224,100US$786.6k62%0.01%
0.63%
Marshall Wace LLP
203,782US$715.3k-22.7%no data
0.56%
Susquehanna International Group, LLP, Asset Management Arm
179,866US$631.3k13.2%no data
0.53%
David Happel
170,518US$598.5k1,090%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/13 10:13
End of Day Share Price 2025/03/13 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sagimet Biosciences Inc. is covered by 9 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Andrea TanGoldman Sachs
Andrea NewkirkGoldman Sachs
Antonio ArceH.C. Wainwright & Co.